FDA Orphan drugs :
Generic Name: Designation:
Doxorubicin liposome Treatment of ovarian cancer.
Trade Name (if present): Sponsor Contact Information
Doxil Alza Corporation
Date Designated 11/4/1998 1550 Plymouth St.
Date Approved PO Box 7210
Date Approved 6/28/1999 Mountain View CA 94039-7210
Base de datos de la FDA sobre el Doxil (el código ODE se refiere a que la patente estaba en vigor por huérfano -Orphan Drug Exclusivity-)
There are no unexpired patents
App No Pro No Exclusivity Code Exclusivity Expiration
050718 001 ODE JUN 28, 2006